Literature DB >> 21256905

Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK.

Jun Xu1, Keane K Y Lai2, Alla Verlinsky2, Aurelia Lugea3, Samuel W French4, Marcus P Cooper5, Cheng Ji6, Hidekazu Tsukamoto3.   

Abstract

BACKGROUND & AIMS: Mechanisms underlying synergistic liver injury caused by alcohol and obesity are not clear. We have produced a mouse model of synergistic steatohepatitis by recapitulating the natural history of the synergism seen in patients for mechanistic studies.
METHODS: Moderate obesity was induced in mice by 170% overnutrition in calories using intragastric overfeeding of high fat diet. Alcohol (low or high dose) was then co-administrated to determine its effects.
RESULTS: Moderate obesity plus alcohol intake causes synergistic steatohepatitis in an alcohol dose-dependent manner. A heightened synergism is observed when a high alcohol dose (32g/kg/d) is used, resulting in plasma ALT reaching 392±28U/L, severe steatohepatitis with pericellular fibrosis, marked M1 macrophage activation, a 40-fold induction of iNos, and intensified nitrosative stress in the liver. Hepatic expression of genes for mitochondrial biogenesis and metabolism are significantly downregulated, and hepatic ATP level is decreased. Synergistic ER stress evident by elevated XBP-1, GRP78 and CHOP is accompanied by hyperhomocysteinemia. Despite increased caspase 3/7 cleavage, their activities are decreased in a redox-dependent manner. Neither increased PARP cleavage nor TUNEL positive hepatocytes are found, suggesting a shift of apoptosis to necrosis. Surprisingly, the synergism mice have increased plasma adiponectin and hepatic p-AMPK, but adiponectin resistance is shown downstream of p-AMPK.
CONCLUSIONS: Nitrosative stress mediated by M1 macrophage activation, adiponectin resistance, and accentuated ER and mitochondrial stress underlie potential mechanisms for synergistic steatohepatitis caused by moderate obesity and alcohol.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21256905      PMCID: PMC3094601          DOI: 10.1016/j.jhep.2010.12.034

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  51 in total

1.  Evidence for LKB1/AMP-activated protein kinase/ endothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, S-adenosylmethionine, and nitric oxide in hepatocyte proliferation.

Authors:  Mercedes Vázquez-Chantada; Usue Ariz; Marta Varela-Rey; Nieves Embade; Nuria Martínez-Lopez; David Fernández-Ramos; Laura Gómez-Santos; Santiago Lamas; Shelly C Lu; M Luz Martínez-Chantar; José M Mato
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

Review 2.  Adiponectin: a key adipokine in alcoholic fatty liver.

Authors:  Min You; Christopher Q Rogers
Journal:  Exp Biol Med (Maywood)       Date:  2009-06-02

Review 3.  "Second hit" models of alcoholic liver disease.

Authors:  Hidekazu Tsukamoto; Keigo Machida; Alla Dynnyk; Hasmik Mkrtchyan
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

Review 4.  JNK signaling in apoptosis.

Authors:  D N Dhanasekaran; E P Reddy
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

Review 5.  Mechanisms of macrophage activation in obesity-induced insulin resistance.

Authors:  Justin I Odegaard; Ajay Chawla
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-10-07

6.  GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.

Authors:  Hélène L Kammoun; Hervé Chabanon; Isabelle Hainault; Serge Luquet; Christophe Magnan; Tatsuro Koike; Pascal Ferré; Fabienne Foufelle
Journal:  J Clin Invest       Date:  2009-04-13       Impact factor: 14.808

7.  Role of SERCA1 truncated isoform in the proapoptotic calcium transfer from ER to mitochondria during ER stress.

Authors:  Mounia Chami; Bénédicte Oulès; György Szabadkai; Rachida Tacine; Rosario Rizzuto; Patrizia Paterlini-Bréchot
Journal:  Mol Cell       Date:  2008-12-05       Impact factor: 17.970

8.  Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decline during alcohol withdrawal.

Authors:  Christa Buechler; Andreas Schäffler; Monika Johann; Markus Neumeier; Philip Köhl; Thomas Weiss; Norbert Wodarz; Paul Kiefer; Claus Hellerbrand
Journal:  J Gastroenterol Hepatol       Date:  2008-12-02       Impact factor: 4.029

Review 9.  Non-alcoholic steatohepatitis and animal models: understanding the human disease.

Authors:  Marta Varela-Rey; Nieves Embade; Usue Ariz; Shelly C Lu; José M Mato; M Luz Martínez-Chantar
Journal:  Int J Biochem Cell Biol       Date:  2008-11-05       Impact factor: 5.085

10.  High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo.

Authors:  Sudheer K Mantena; Denty Paul Vaughn; Kelly K Andringa; Heather B Eccleston; Adrienne L King; Gary A Abrams; Jeannette E Doeller; David W Kraus; Victor M Darley-Usmar; Shannon M Bailey
Journal:  Biochem J       Date:  2009-01-01       Impact factor: 3.857

View more
  71 in total

1.  Human immunodeficiency virus protease inhibitors modulate Ca2+ homeostasis and potentiate alcoholic stress and injury in mice and primary mouse and human hepatocytes.

Authors:  Eddy Kao; Masao Shinohara; Min Feng; Mo Yin Lau; Cheng Ji
Journal:  Hepatology       Date:  2012-06-11       Impact factor: 17.425

Review 2.  Binge drinking: Burden of liver disease and beyond.

Authors:  Susana Llerena; María Teresa Arias-Loste; Angela Puente; Joaquín Cabezas; Javier Crespo; Emilio Fábrega
Journal:  World J Hepatol       Date:  2015-11-28

3.  Decreased Macrophage Autophagy Promotes Liver Injury and Inflammation from Alcohol.

Authors:  Ghulam Ilyas; Francesca Cingolani; Enpeng Zhao; Kathryn Tanaka; Mark J Czaja
Journal:  Alcohol Clin Exp Res       Date:  2019-04-29       Impact factor: 3.455

Review 4.  Alcoholic liver disease: the gut microbiome and liver cross talk.

Authors:  Phillipp Hartmann; Caroline T Seebauer; Bernd Schnabl
Journal:  Alcohol Clin Exp Res       Date:  2015-05       Impact factor: 3.455

Review 5.  Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.

Authors:  Min You; Alvin Jogasuria; Kwangwon Lee; Jiashin Wu; Yanqiao Zhang; Yoon Kwang Lee; Prabodh Sadana
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

6.  Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease.

Authors:  Xiaobing Dou; Yongliang Xia; Jing Chen; Ying Qian; Songtao Li; Ximei Zhang; Zhenyuan Song
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

7.  P2X7 Receptor Antagonist A804598 Inhibits Inflammation in Brain and Liver in C57BL/6J Mice Exposed to Chronic Ethanol and High Fat Diet.

Authors:  Daniel Freire; Rachel E Reyes; Ared Baghram; Daryl L Davies; Liana Asatryan
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-23       Impact factor: 4.147

Review 8.  Beverage consumption and paediatric NAFLD.

Authors:  Antonella Mosca; Claudia Della Corte; Maria Rita Sartorelli; Francesca Ferretti; Francesco Nicita; Andrea Vania; Valerio Nobili
Journal:  Eat Weight Disord       Date:  2016-08-26       Impact factor: 4.652

9.  Leptin deficiency contributes to the pathogenesis of alcoholic fatty liver disease in mice.

Authors:  Xiaobing Tan; Xiuhua Sun; Qiong Li; Yantao Zhao; Wei Zhong; Xinguo Sun; Wei Jia; Craig J McClain; Zhanxiang Zhou
Journal:  Am J Pathol       Date:  2012-07-27       Impact factor: 4.307

Review 10.  Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD).

Authors:  Helmut K Seitz; Sebastian Mueller; Claus Hellerbrand; Suthat Liangpunsakul
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.